甲胎蛋白阴性复发性小肝癌超声造影特征分析
该回顾性研究分析116例复发性小肝细胞癌患者共132个病灶的超声造影表现,比较51例AFP阴性患者59个病灶与65例AFP阳性患者73个病灶的血流动力学参数。结果显示AFP阴性组达峰时间、等增强开始时间、低增强开始时间均显著延长,门脉期和延迟期等增强比例更高,动脉期高增强比例无差异。AFP阴性复发性小肝癌超声造影呈快进慢出且多样化不典型趋势。
要点
- AFP阴性复发性小肝癌超声造影以快进慢出为主,但表现多样化、不典型。
- AFP阴性组达峰时间、等增强及低增强开始时间均较AFP阳性组延长。
- AFP阴性组门脉期和延迟期等增强比例更高,动脉期高增强比例无差异。
核心结论
- AFP阴性复发性小肝癌超声造影灌注模式以快进慢出为主,呈多样化、不典型趋势,认识其规律有助于提高早期检出率。
研究设计与样本
- 回顾性分析116例复发性小肝细胞癌患者132个病灶的超声造影表现,其中AFP阴性组51例59个病灶,AFP阳性组65例73个病灶。
主要发现
- AFP阴性组达峰时间为(23.22±5.08)s,AFP阳性组为(20.30±3.41)s,差异有统计学意义(P<0.05)。
- AFP阴性组等增强开始时间为(59.44±39.75)s,AFP阳性组为(40.75±16.16)s,差异有统计学意义(P<0.05)。
- AFP阴性组低增强开始时间为(102.89±44.45)s,AFP阳性组为(87.08±25.27)s,差异有统计学意义(P<0.05)。
- AFP阴性组门脉期等增强比例为59.3%,AFP阳性组为37.0%;延迟期分别为16.9%和4.1%,差异均有统计学意义(均P<0.05)。
- 两组动脉期高增强比例分别为94.9%和98.6%,差异无统计学意义(P>0.05);增强始增时间分别为(14.87±6.00)s和(14.35±5.30)s,差异无统计学意义(P>0.05)。
临床怎么用
- 对AFP阴性复发性小肝癌患者,超声造影需关注达峰时间、等增强及低增强开始时间延长的快进慢出特点。
- 门脉期和延迟期等增强比例较高提示AFP阴性复发性小肝癌造影表现不典型,需结合多期增强模式判读。
局限性
- 本研究为回顾性分析,样本来自单中心,结论需前瞻性多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the characteristics of contrast-enhanced ultrasound (CEUS) in alpha-fetoprotein (AFP)-negative recurrent small hepatocellular carcinoma (rsHCC). Methods: The imaging characteristics of CEUS were retrospectively analyzed in 132 lesions from 116 patients with rsHCC, including 59 lesions from 51 AFP-negative patients and 73 lesions from 65 AFP-positive patients. The hemodynamic parameters such as contrast-enhanced onset time, time-to-peak, isoenhancement start time, low-enhancement start time, and perfusion mode were compared between two groups. Results: The time-to-peak, isoenhancement start time, low-enhancement start time of AFP-negative group were significantly increased than those in AFP-positive group (23.22±5.08)s vs. (20.30±3.41)s, (59.44±39.75)s vs. (40.75±16.16)s, (102.89±44.45)s vs. (87.08±25.27)s (all of P<0.05). Meanwhile, the proportion of isoenhancement during the portal and late phases in AFP-negative group was significantly higher than those in AFP-positive group (59.3% vs. 37.0%, 16.9% vs. 4.1%; all of P<0.05). However, there was no significant difference between the two groups in the enhancement start time (14.87±6.00)s vs. (14.35±5.30)s (P>0.05) as well as isoenhancement proportion in the arterial phase (94.9% vs. 98.6%, P>0.05). Conclusions: The enhancement pattern of CEUS in AFP-negative rsHCC patients was "fast-in and slow-out" with a diverse and atypical trend. Recognizing its regular features will facilitate the early detection of AFP-negative rsHCC. 目的: 分析甲胎蛋白(AFP)阴性复发性小肝细胞性肝癌(rsHCC)的超声造影特征。 方法: 回顾性分析116例rsHCC患者132个病灶的超声造影表现,其中AFP阴性rsHCC组51例(59个病灶),AFP阳性rsHCC组65例(73个病灶),比较两组患者病灶的超声造影强化始增时间、达峰时间、等增强开始时间、低增强开始时间以及灌注模式等血流动力学参数。 结果: AFP阴性组rsHCC超声造影表现以快进慢出为主。AFP阴性rsHCC组病灶的达峰时间、等增强开始时间和低增强开始时间分别为(23.22±5.08)s、(59.44±39.75)s和(102.89±44.45)s,AFP阳性rsHCC组病灶的达峰时间、等增强开始时间和低增强开始时间分别为(20.30±3.41)s、(40.75±16.16)s和(87.08±25.27)s;差异均有统计学意义(均P<0.05)。AFP阴性rsHCC组和AFP阳性rsHCC组病灶在门脉期呈等增强的比例分别为59.3%和37.0%,在延迟期呈等增强的比例分别为16.9%和4.1%,差异均有统计学意义(均P<0.05)。AFP阴性rsHCC组和AFP阳性rsHCC组病灶动脉期呈高增强的比例分别为94.9%和98.6%,差异无统计学意义(P>0.05)。 结论: AFP阴性rsHCC超声造影灌注模式主要以快进慢出为主,且呈多样化、不典型趋势,认识其规律变化,有助于提高AFP阴性rsHCC的早期检出率。.
引用
- Fu XB, Yuan JJ, Yang L, et al. [Characteristics of contrast-enhanced ultrasound in alpha-fetoprotein-negative recurrent small hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32575942. doi:10.3760/cma.j.cn112152-20190408-00222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。